Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Form 8.3 APAX GLOBAL ALPHA LTD

16 Sep 2025 13:23

RNS Number : 5618Z
Barclays PLC
16 September 2025
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

APAX GLOBAL ALPHA LTD

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

15 Sep 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

Ordinary NPV

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

5,971,607

1.24%

157,760

0.03%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

47,227

0.01%

5,967,064

1.24%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

6,018,834

1.25%

6,124,824

1.27%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

Ordinary NPV

Purchase

15,839

1.6382 GBP

Ordinary NPV

Purchase

1,968

1.6380 GBP

Ordinary NPV

Sale

429,330

1.6360 GBP

Ordinary NPV

Sale

26,591

1.6376 GBP

Ordinary NPV

Sale

15,983

1.6417 GBP

Ordinary NPV

Sale

15,038

1.6379 GBP

Ordinary NPV

Sale

4,139

1.6400 GBP

Ordinary NPV

Sale

4,024

1.6340 GBP

Ordinary NPV

Sale

3,871

1.6380 GBP

Ordinary NPV

Sale

3,867

1.6438 GBP

Ordinary NPV

Sale

2,167

1.6419 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

Ordinary NPV

SWAP

Decreasing Short

429,330

1.6360 GBP

Ordinary NPV

SWAP

Decreasing Short

15,038

1.6379 GBP

Ordinary NPV

SWAP

Decreasing Short

1,903

1.6380 GBP

Ordinary NPV

SWAP

Decreasing Short

15,473

1.6398 GBP

Ordinary NPV

SWAP

Decreasing Short

15,729

1.6406 GBP

Ordinary NPV

CFD

Decreasing Short

9,795

1.6378 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercise

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

16 Sep 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETPKABKBBKDKCD
Date   Source Headline
14th Sep 202011:24 amRNSDirector/PDMR Shareholding
10th Sep 202011:39 amRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNS2020 Interim Dividend
25th Aug 20207:00 amRNS2020 Interim Report and Accounts
25th Aug 20207:00 amRNS2020 Interim Results Highlights
17th Aug 20207:00 amRNSInitial Public Offering of Duck Creek
10th Aug 20209:28 amRNSDirector Declaration - Additional Directorship
22nd Jul 20207:01 amRNSApax Fund Valuation Comments
22nd Jul 20207:00 amRNSApax Funds’ Valuations as at 30 June 2020
25th Jun 20207:00 amRNS2020 AGA Investor Update
17th Jun 20205:26 pmRNSDirector/PDMR Shareholding
16th Jun 20207:00 amRNSNotice of Interim Results
11th Jun 20205:03 pmRNSDirector Declaration - Additional Directorship
9th Jun 202010:04 amRNSNotice of Investor Update
8th Jun 202012:07 pmRNSSecond Price Monitoring Extn
8th Jun 202012:02 pmRNSPrice Monitoring Extension
4th Jun 20209:42 amRNSDirector/PDMR Shareholding
4th Jun 20209:42 amRNSDirector/PDMR Shareholding
1st Jun 202012:08 pmRNSSecond Price Monitoring Extn
1st Jun 202012:02 pmRNSPrice Monitoring Extension
28th May 202012:07 pmRNSSecond Price Monitoring Extn
28th May 202012:02 pmRNSPrice Monitoring Extension
27th May 20202:46 pmRNSDirector/PDMR Shareholding
27th May 20202:45 pmRNSDirector/PDMR Shareholding
22nd May 202012:15 pmRNSDirector/PDMR Shareholding
20th May 20204:36 pmRNSDirector/PDMR Shareholding
18th May 20203:38 pmRNSDirector/PDMR Shareholding
15th May 20207:00 amRNSQuarterly results for 31 March 2020
14th May 20205:29 pmRNSDirector Declaration - Additional Directorship
13th May 20207:00 amRNSApax Funds’ Valuations as at 31 March 2020
29th Apr 202012:32 pmRNSResult of AGM
29th Apr 202011:41 amRNSDisclosure of rights attached to equity shares
21st Apr 20201:12 pmRNSAGM Update
20th Apr 20204:35 pmRNSPrice Monitoring Extension
15th Apr 20204:42 pmRNSSecond Price Monitoring Extn
15th Apr 20204:36 pmRNSPrice Monitoring Extension
15th Apr 202012:07 pmRNSSecond Price Monitoring Extn
15th Apr 202012:02 pmRNSPrice Monitoring Extension
14th Apr 202012:08 pmRNSSecond Price Monitoring Extn
14th Apr 202012:03 pmRNSPrice Monitoring Extension
9th Apr 20204:41 pmRNSSecond Price Monitoring Extn
9th Apr 20204:35 pmRNSPrice Monitoring Extension
1st Apr 202012:08 pmRNSSecond Price Monitoring Extn
1st Apr 202012:02 pmRNSPrice Monitoring Extension
1st Apr 20207:00 amRNSAGM Update
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
26th Mar 20201:13 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.